Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
SUSPENDED
NCT00280189

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

Sponsor: University of Pittsburgh

View on ClinicalTrials.gov

Summary

The purpose of this study is to assess short and long term outcomes after radiofrequency ablation (RFA) of pulmonary malignancies in patients who are not candidates for surgical resection. This study will evaluate the efficacy of RFA for the treatment of lung tumors by assessing its impact on local tumor control, progression free survival, overall survival, dyspnea score and quality of life (QOL).

Official title: A Prospective Study of Outcomes of Radiofrequency Ablation of Lung Tumors

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

72

Start Date

2003-09

Completion Date

2028-03

Last Updated

2026-04-14

Healthy Volunteers

No

Interventions

PROCEDURE

Radiofrequency ablation of pulmonary malignancies

Radiofrequency ablation is an inpatient procedure typically requiring one overnight stay in the hospital.

BEHAVIORAL

Quality of life assessment

Quality of life assessment is administered prior to the Radiofrequency ablation procedure and every 3 months for 1 year following the procedure.

BEHAVIORAL

Assessment of pain

Pain scores are obtained prior to the procedure, daily X 7 starting on the day of surgery, and then every 3 months for 1 year.

Locations (1)

Hillman Cancer Center

Pittsburgh, Pennsylvania, United States